Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HCW Biologics Inc. Common Stock
HCWB | US
0.36
USD0.03
8.06%
HCWB | US
About HCW Biologics Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
10/04/2026
Close
0.36
Open
0.34
High
0.37
Low
0.30
HCW Biologics Inc. a clinical-stage biopharmaceutical company focuses on discovering and developing novel immunotherapies for chronic low-grade inflammation and age-related diseases. The company's lead products include HCW9218 which is an injectable immunotherapeutic for patients with pancreatic ovarian breast prostate and colorectal cancers as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases such as alopecia areata and metabolic diseases. It also develops HCW9201 a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar Florida.
View LessHCWB | US
Risk
338.5
Sharpe
-0.52
Luna's Score
40/100
Recommendation
Sell
Luna says (HCWB | US)
What's Working
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
174.7%1 month
338.5%3 months
217.3%6 months
172.2%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.80
Debt to equity
-1.59
Debt to assets
0.37
Ent. to EBITDA
-3.63
Ent. to rev.
7.66
PEG
-
Other Fundamentals
EBITDA
-36.58M
MarketCap
15.90M
MarketCap(USD)
15.90M
Div. yield
-
Op. margin
-2.24K
Erngs. growth
-
Rev. growth
-0.60
Ret. on equity
-344.32
Short ratio
0.87
Short perc.
0.14
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.18
Range1M
0.92
Range3M
1.40
Volumes: Market Activity
Rel. volume
0.03
Price X volume
285.03K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.63 | - | Cheaper |
| Ent. to Revenue | 7.66 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.80 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 217.33 | - | Riskier |
| Debt to Equity | -1.59 | -1.23 | Cheaper |
| Debt to Assets | 0.37 | 0.25 | Expensive |
| Market Cap | 15.90M | - | Emerging |
